Last update 01 Nov 2024

SLAMF6 x DNA

Basic Info

Related Targets
SLAMF6DNA

Related

1
Drugs associated with SLAMF6 x DNA
SGN-CD352A
Target
DNA x SLAMF6
Mechanism
DNA inhibitors [+1]
Active Org.-
Originator Org.
Ligand Pharmaceuticals, Inc.Ligand Pharmaceuticals, Inc.
Active Indication-
Inactive Indication
Multiple Myeloma [+2]
Drug Highest PhaseDiscontinued
First Approval Ctry. / Loc.-
First Approval Date20 Jan 1800
1
Clinical Trials associated with SLAMF6 x DNA
NCT02954796 / TerminatedPhase 1
Phase 1 Study of SGN-CD352A in Patients With Relapsed or Refractory Multiple Myeloma
100 Clinical Results associated with SLAMF6 x DNA
Login to view more data
100 Translational Medicine associated with SLAMF6 x DNA
Login to view more data
0 Patents (Medical) associated with SLAMF6 x DNA
Login to view more data

Analysis

Perform a panoramic analysis of this field.
login
or
view full example data
Perform a panoramic analysis of this field.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free